CD8A and type 2 diabetes mellitus: Treatment with anti-CD8 antibodies can block CD8+ T cell infiltration into injured tissues and decrease the release of pro-inflammatory factors after ischemic injury in T2DM mice, thereby promoting vascular regeneration in damaged tissues (204), which may provide new directions for the treatment of diabetic complications such as AS and DR.